TMCnet News

Mystic Pharmaceuticals Unveils The Next Generation Of Patient-Centric Sublingual Drug Delivery Devices
[July 15, 2014]

Mystic Pharmaceuticals Unveils The Next Generation Of Patient-Centric Sublingual Drug Delivery Devices


AUSTIN, Texas --(Business Wire)--

Mystic Pharmaceuticals, Inc. today announced the availability of its Javelin Sublingual™ drug delivery devices. Javelin Sublingual dispensers utilized Mystic's VersiDoser® and VRx2™ platform technology, and are offered in mono-dose and multi-dose configurations. Sublingual and buccal delivery provides non-invasive, delivery of drugs, peptides, proteins and enzymes through mucosal surfaces in the oral cavity. This route avoids first pass metabolism, provides rapid systemic uptake into the body and can be self-administered by the patient. Applications include the delivery of therapeutics for pain, cardiovascular, allergy, seizure, sedation, emesis, hormones, diabetes and vaccines.

Javelin Sublingual dispensers utilize Mystic Pharmaceuticals' VersiDoser® and VRx2™ platform technol ...

Javelin Sublingual dispensers utilize Mystic Pharmaceuticals' VesiDoser® and VRx2™ platform technology. (Photo: Business Wire)



Based on Mystic's VersiDoser® and VRx2™ delivery technology, Javelin Sublingual dispensers provide precise dose delivery for liquid, powder and reconstituted powder medications. All Javelin dispensers incorporate patient-centric ergonomic design features such as side actuation, no priming and contoured surfaces to facilitate ease of use, comfort and safety for the patient.


Each Javelin dispenser is customized to the pharma manufacturer's Target (News - Alert) Product Profile and technical specifications through Mystic's product integration process. Utilizing the VersiDoser or VRx2 Delivery Platform technology, Mystic can cost effectively provide an optimized commercial product that delivers value for both the patient and the pharmaceutical manufacturer. This approach eliminates the compromises that often arise with commodity off the shelf dispensers.

Mystic will produce and fill Javelin Sublingual dispensers at its Austin, Texas manufacturing facility and internationally through its strategic manufacturing partners. For more information please visit http://www.mysticpharmaceuticals.com

About Mystic Pharmaceuticals, Inc.

Mystic Pharmaceuticals® is an integrated specialty pharmaceutical manufacturer based in Austin, Texas. Mystic provides precision unit dose delivery solutions for pharmaceuticals, biopharmaceuticals and biologics for intranasal, nose-to-brain, ophthalmic, sublingual, and otic applications. Mystic combines its novel delivery systems with pharmaceuticals and biologics under development by Mystic and its partners, to meet the expanding global market demand for healthcare products that are safer, simpler to use and cost effective. For more information please visit the Mystic website at: http://www.mysticpharmaceuticals.com


[ Back To TMCnet.com's Homepage ]